VitaVitro Biotech provides integrated solutions for assisted reproduction laboratories, focusing on optimizing laboratory workflows and enhancing the efficiency of assisted reproductive technology (ART) processes. Their offerings include technical support and specialized products that improve the success rates of procedures such as in vitro fertilization (IVF) and embryo culture.
Funding
$15.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Assisted reproductive technology (ART) laboratories require specialized products and technical expertise to optimize workflows and improve the success rates of procedures like in vitro fertilization (IVF). Inconsistent quality and performance of consumables can lead to suboptimal outcomes in embryo development and cryopreservation.
Solution
VitaVitro Biotech provides a comprehensive suite of products and technical support designed to enhance the efficiency and effectiveness of ART laboratory processes. Their portfolio includes cryopreservation systems, embryo production systems, IVF/ICSI solutions, sperm processing media, and specialized needles and catheters. VitaVitro's offerings are designed to provide reliable and consistent performance, helping ART labs to improve embryo quality, streamline workflows, and ultimately increase pregnancy rates. The company emphasizes the use of thoroughly tested components, such as TCM-199 and Hepes buffer in their holding media, to ensure stability and reliability.
Target Audience
VitaVitro Biotech serves assisted reproductive technology (ART) laboratories, IVF clinics, and reproductive medicine centers seeking to improve their laboratory workflows and enhance the success rates of their procedures.
Features
- Cryopreservation systems for oocyte and embryo vitrification and warming
- Culture media and oil optimized for embryo development
- Specialized dishes (WOW\Humdish) for improved culture conditions
- Media for fertilization, gamete buffering, and hyaluronidase treatment during IVF/ICSI
- Flushing buffer media for efficient oocyte retrieval
- Sperm washing, gradient, and freezing media for optimal sperm preparation
- Oocyte retrieval needles, embryo transfer catheters, IUI catheters, and micromanipulation pipettes
- Flinders Technology Associates (FTA) cards for sample collection and storage